<DOC>
	<DOCNO>NCT00230607</DOCNO>
	<brief_summary>The purpose study observe potential effect Fabrazyme ( agalsidase beta ) treatment lactation growth , development , immunologic response infant born mother Fabry disease treat Fabrazyme lactation . There 3 participation scenario : mother/infant full participation , mother full participation/infant development assessment , mother full participation/infant participation . Whether mother continue lactate assess visit . If mother longer lactate , mother discontinue study continue follow Fabry Registry . The infant ( participate ) follow development remainder 24 month study .</brief_summary>
	<brief_title>A Study Effects Fabrazyme ( Agalsidase Beta ) Mother 's Lactation Growth , Development Immunologic Response Their Infants</brief_title>
	<detailed_description>NOTE : Estimated Enrollment : 10 mother 10 infant</detailed_description>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Mother must provide sign write informed consent participate study . Mother must enrol Fabry Registry receive Fabrazyme ( agalsidase beta ) lactating . Mother must agree adhere Fabry Registry recommend schedule assessment medical history , pregnancy outcome , genotyping , antibody test . Mother must agree adhere schedule evaluation study . Infant must sign write informed consent parent ( ) /legal guardian ( ) participate study . Infant must bear mother receive Fabrazyme ( agalsidase beta ) lactation . Infant must receive breast milk mother . Infant must agreement parent ( ) /legal guardian ( ) adhere schedule evaluation study . The mother infant exclude study mother receive investigational drug within 30 day prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>alpha Galactosidase A</keyword>
	<keyword>aGAL</keyword>
	<keyword>rh aGAL</keyword>
	<keyword>Fabry</keyword>
	<keyword>GL3</keyword>
	<keyword>Fabrazyme</keyword>
	<keyword>Lysosomal Storage Disorder</keyword>
	<keyword>Enzyme Replacement Therapy ( ERT )</keyword>
</DOC>